Mimedx Group Stock Performance
| MDXG Stock | USD 6.40 0.07 1.11% |
The company secures a Beta (Market Risk) of 1.19, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MiMedx will likely underperform. At this point, MiMedx Group has a negative expected return of -0.084%. Please make sure to verify MiMedx's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MiMedx Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, MiMedx is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 82 M | |
| Total Cashflows From Investing Activities | -9.6 M |
MiMedx Relative Risk vs. Return Landscape
If you would invest 692.00 in MiMedx Group on October 9, 2025 and sell it today you would lose (48.00) from holding MiMedx Group or give up 6.94% of portfolio value over 90 days. MiMedx Group is currently does not generate positive expected returns and assumes 2.5338% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than MiMedx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MiMedx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MiMedx Group, and traders can use it to determine the average amount a MiMedx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0331
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDXG |
Based on monthly moving average MiMedx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MiMedx by adding MiMedx to a well-diversified portfolio.
MiMedx Fundamentals Growth
MiMedx Stock prices reflect investors' perceptions of the future prospects and financial health of MiMedx, and MiMedx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MiMedx Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 813.62 M | ||||
| Shares Outstanding | 148.1 M | ||||
| Price To Earning | 23.73 X | ||||
| Price To Book | 3.92 X | ||||
| Price To Sales | 2.41 X | ||||
| Revenue | 348.88 M | ||||
| EBITDA | 65.35 M | ||||
| Cash And Equivalents | 72.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 24.84 M | ||||
| Debt To Equity | 0.69 % | ||||
| Book Value Per Share | 1.61 X | ||||
| Cash Flow From Operations | 66.2 M | ||||
| Earnings Per Share | 0.27 X | ||||
| Total Asset | 263.92 M | ||||
| Retained Earnings | (91.26 M) | ||||
| Current Asset | 96.31 M | ||||
| Current Liabilities | 26.78 M | ||||
About MiMedx Performance
By analyzing MiMedx's fundamental ratios, stakeholders can gain valuable insights into MiMedx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MiMedx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MiMedx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. Mimedx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 811 people.Things to note about MiMedx Group performance evaluation
Checking the ongoing alerts about MiMedx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MiMedx Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MiMedx Group generated a negative expected return over the last 90 days | |
| About 72.0% of the company shares are owned by institutional investors |
- Analyzing MiMedx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MiMedx's stock is overvalued or undervalued compared to its peers.
- Examining MiMedx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MiMedx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MiMedx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MiMedx's stock. These opinions can provide insight into MiMedx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |